Physician profile
Gregory Altman
NPI 1285633123
$2,150.85
in general payments reported to CMS, 2019-2025
11 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $120 · 2021: $221 · 2022: $588 · 2023: $58.09 · 2024: $369 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627 · Education: $75.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.36 |
| Education | $75.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $809.19 | 2019-2025 | Na, Va-Lcp, Fibulink |
| Innovation Technologies INC | $611.91 | 2020-2023 | Irrisept |
| Smith+Nephew, INC. | $224.17 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $192.54 | 2019-2024 | T2 Alpha |
| Ferring Pharmaceuticals INC. | $164.67 | 2019-2021 | |
| Carbofix Orthopedics INC | $64.64 | 2019 | |
| Medical Device Business Services, INC. | $27.10 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.73 | 2023 | Exparel, Iovera, Zilretta |
| Bioventus LLC | $18.19 | 2019 | |
| Acell, INC. | $16.71 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Altman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.